<DOC>
	<DOC>NCT01147315</DOC>
	<brief_summary>The main objective of the study is the cure of osteoradionecrosis (ORN) at 12 months.</brief_summary>
	<brief_title>ORN Study: Curative Treatment of Osteoradionecrosis (ORN) With Hybrid Bone Substitution</brief_title>
	<detailed_description />
	<mesh_term>Osteoradionecrosis</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<criteria>Adult patients (between 18 and 75 years) affiliated with an appropriate social security system, diagnosed as suffering from symptomatic ORN, radiologically confirmed, for which surgery is indicated Presence maximum of 2 outbreaks of ORN Oncological remission of the original tumor site for 1 year and for 3 years if the ORN is in the contact or close to the initial tumoral site ECOG performance status 0, 1 or 2 ORN symptomatic accessible to the conservation of at least one cortical mandibular basilar Signed informed consent Oncological treatment Haematologic background Current bone necrosis consecutive or concurrent to taking bisphosphonates Extension of ORN does not allow the retention of a mandibular rod (bicortical form) Presence of fracture complicating ORN Bisphosphonates during the last year Contraindications to the removal of iliac or sternum bone marrow Contraindication for general anesthesia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>mandibular osteoradionecrosis</keyword>
	<keyword>hybrid bone substitution</keyword>
	<keyword>calcium-phosphate ceramic biomaterial</keyword>
	<keyword>autologous bone marrow</keyword>
</DOC>